| Literature DB >> 21789045 |
Xiaoling Lu1, Xiaoyu Liu, Cong Long, Guoxiang Wang, Yun Gao, Junhua Liu, Binghua Jiao.
Abstract
East China Sea is one of the four sea areas in China, which possesses peculiar ecological environment and many kinds of living creatures, especially the microorganisms. We established the East China Sea microorganism library (during 2006-2010) for the first time, which stored about 30000 strains that covered most kinds of the species. In this paper, 395 pure strains of East China Sea microorganism library which belong to 33 different genera were mainly introduced. Sulfitobacter, Halomonas, Bacillus, Pseudoalteromonas, and Idiomarina were the most dominant species. On the large-scale biological activity screening of the 395 strains, 100 strains possess different biological activities based on different screening models, of which 11.4% strains have antibacterial activities, 15.9% have cytotoxicity activities, and 6.1% have antioxidation activities. Besides, the secondary metabolites of 6 strains with strong biological activities were studied systematically; diketopiperazines and macrocyclic lactones are the active secondary metabolites. The species and the biological activity of microorganisms diversity, the abundant structure type of the secondary metabolites, and their bioactivities all indicate that East China Sea is a potent marine microorganisms-derived developing resource for drug discovery.Entities:
Year: 2011 PMID: 21789045 PMCID: PMC3140816 DOI: 10.1155/2011/806485
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Taxonomy of 395 strains.
| Genus | No. | Genus | No. | Genus | No. |
|---|---|---|---|---|---|
|
| 8 |
| 3 |
| 4 |
|
| 30 |
| 7 |
| 6 |
|
| 2 |
| 1 |
| 10 |
|
| 5 |
| 42 |
| 36 |
|
| 9 |
| 2 |
| 3 |
|
| 2 |
| 4 |
| 3 |
|
| 5 |
| 1 |
| 4 |
|
| 6 |
| 7 |
| 5 |
|
| 69 |
| 12 |
| 2 |
|
| 5 |
| 2 |
| 10 |
|
| 62 |
| 8 |
| 20 |
Strains with strongest antibacterial activities.
| Strain no. | Genus |
|
|
|
|---|---|---|---|---|
| ZJ8112 |
| ++ | − | − |
| F121112 |
| + | − | − |
| F8712 |
| − | − | − |
| F321122 |
| − | − | − |
| 201721 |
| ++ | − | + |
| XB16 |
| − | − | − |
| MZ0306A2 |
| + | + | ++ |
| MZ0208A2 |
| − | + | ++ |
| MZ0204A3 |
| − | + | + |
| P3001 |
| − | + | +++ |
| P4004A |
| − | + | + |
| P16006B |
| − | +++ | − |
| P3009B |
| − | +++ | − |
| P16011A |
| − | + | − |
| P16010C |
| − | ++ | − |
| P4004C |
| − | ++ | ++ |
| XF22−2 |
| − | − | ++ |
| P4003B |
| − | − | + |
| P12012B |
| − | − | ++ |
Note: “+++”means the diameters of the inhibition zone exceeding 15 mm; “++” means the diameters of the inhibition zone 10–15 mm; “+” means the diameter of the inhibition zone exceeding 6–10 mm; “−”means no antibacterial activities.
Strains with strongest cytotoxic activities of the 395 strains.
| Strain no. | Genus | Sensitive tumor strain | Inhibitory ratio |
|---|---|---|---|
| F321121 |
| SMMC 7721 | 17.6% |
| P12002 |
| HeLa, MCF | 35%, 12% |
| F81612 |
| HeLa, SW1990 | 39%, 9.3% |
| F81611 |
| HeLa | 29.1% |
| P3001 |
| HepG2 | 28% |
| P3002 |
| HepG2, MCF | 27% |
| P16006A |
| HepG2 | 29% |
| P16006B |
| HepG2 | 32% |
| P16001 |
| HeLa, MCF | 18.4%, 20.4% |
| P4003B |
| HepG2, P388 | 31%, 7.9% |
| P12006A2 |
| HepG2 | 31% |
| P4006B |
| HepG2, P388 | 42%, 13% |
| MZ0206A2 |
| SMMC7721, S180 | 11%, 19% |
| MZ0208A2 |
| SMMC 7721 | 21% |
| P16003 |
| HepG2 | 23% |
| P4004B |
| HepG2 | 31% |
| P12002 |
| HepG2 | 28.7% |
| P12012B |
| HepG2, SW1990 | 14.9%, 17% |
| P12004D |
| HepG2, S180 | 16.7%, 23% |
All the cultured broths of the strains were tested at a fixed concentration 500 μg/mL. Each experiment was repeated 3 times, and the inhibitory ratio was the average of the 3 results.
Figure 1Strains of Sulfitobacter sp. with cytotoxicity activities to HepG2 cell line. All the cultured broth of the strains were tested at a fixed concentration 500 μg/mL. Each experiment was repeated 3 times, and the inhibitory ratio was the average of the 3 results.
Figure 224 strains with best antioxidant activity in DPPH· assay. All the cultured broths of the strains were tested at a fixed concentration 375 μg/mL. Each experiment was repeated 3 times, and the inhibitory ratio was the average of the 3 results.
Figure 330 strains with best antioxidant activity in ABTS·+ assay. All the cultured broths of the strains were tested at a fixed concentration 375 μg/mL. Each experiment was repeated 3 times, and the inhibitory ratio was the average of the 3 results.
Overview of the 6 strains with biological activities.
| No. | Genus | Biological activity | Main type of the secondary metabolites |
|---|---|---|---|
| F81612 |
| Antibacterial | cyclopeptide, indole derivatives, and macrolide |
| F201721 |
| Antibacterial | cyclopeptide, indole derivatives, and macrolide |
| F8712 |
| Cytotoxicity | cyclopeptide |
| F321122 |
| Cytotoxicity | cyclopeptide and indole derivatives |
| F121122 |
| Cytotoxicity | cyclopeptide |
| M44 |
| Cytotoxicity | cyclopeptide |
Figure 4The new secondary metabolites and the compounds with the good biological activities isolated from the strain F201721, F81612, F8712, F321122, F121122, and M44.